Bronchopulmonary dysplasia or chronic lung disease: an appeal to standardize nomenclature
نویسندگان
چکیده
منابع مشابه
Bronchopulmonary dysplasia and chronic lung disease of infancy: strategies for prevention and management.
Remarkable advances in the treatment of neonatal respiratory disorders, such as antenatal glucocorticoid therapy, surfactant replacement therapy and alternative modes of ventilation, have reduced neonatal mortality and acute respiratory morbidity. However, bronchopulmonary dysplasia and chronic lung disease of infancy remain a substantial complication, especially among the most immature infants...
متن کاملBronchopulmonary Dysplasia: Chronic Lung Disease of Infancy and Long-Term Pulmonary Outcomes
Bronchopulmonary dysplasia (BPD) is a chronic lung disease most commonly seen in premature infants who required mechanical ventilation and oxygen therapy for acute respiratory distress. While advances in neonatal care have resulted in improved survival rates of premature infants, limited progress has been made in reducing rates of BPD. Lack of progress may in part be attributed to the limited t...
متن کاملLinking bronchopulmonary dysplasia to adult chronic lung diseases: role of WNT signaling
Bronchopulmonary dysplasia (BPD) is one of the most common chronic lung diseases in infants caused by pre- and/or postnatal lung injury. BPD is characterized by arrested alveolarization and vascularization due to extracellular matrix remodeling, inflammation, and impaired growth factor signaling. WNT signaling is a critical pathway for normal lung development, and its altered signaling has been...
متن کاملPolicy statement--postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia.
The purpose of this revised statement is to review current information on the use of postnatal glucocorticoids to prevent or treat bronchopulmonary dysplasia in the preterm infant and to make updated recommendations regarding their use. High-dose dexamethasone (0.5 mg/kg per day) does not seem to confer additional therapeutic benefit over lower doses and is not recommended. Evidence is insuffic...
متن کاملPolicy Statement—Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary Dysplasia
The purpose of this revised statement is to review current information on the use of postnatal glucocorticoids to prevent or treat bronchopulmonary dysplasia in the preterm infant and to make updated recommendations regarding their use. High-dose dexamethasone (0.5 mg/kg per day) does not seem to confer additional therapeutic benefit over lower doses and is not recommended. Evidence is insuffic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Research
سال: 2018
ISSN: 0031-3998,1530-0447
DOI: 10.1038/s41390-018-0152-3